#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis


IgA nephropathy (IgAN), major cause of kidney failure worldwide, is common in Asians, moderately prevalent in Europeans, and rare in Africans. It is not known if these differences represent variation in genes, environment, or ascertainment. In a recent GWAS, we localized five IgAN susceptibility loci on Chr.6p21 (HLA-DQB1/DRB1, PSMB9/TAP1, and DPA1/DPB2 loci), Chr.1q32 (CFHR3/R1 locus), and Chr.22q12 (HORMAD2 locus). These IgAN loci are associated with risk of other immune-mediated disorders such as type I diabetes, multiple sclerosis, or inflammatory bowel disease. We tested association of these loci in eight new independent cohorts of Asian, European, and African-American ancestry (N = 4,789), followed by meta-analysis with risk-score modeling in 12 cohorts (N = 10,755) and geospatial analysis in 85 world populations. Four susceptibility loci robustly replicated and all five loci were genome-wide significant in the combined cohort (P = 5×10−32–3×10−10), with heterogeneity detected only at the PSMB9/TAP1 locus (I2 = 0.60). Conditional analyses identified two new independent risk alleles within the HLA-DQB1/DRB1 locus, defining multiple risk and protective haplotypes within this interval. We also detected a significant genetic interaction, whereby the odds ratio for the HORMAD2 protective allele was reversed in homozygotes for a CFHR3/R1 deletion (P = 2.5×10−4). A seven–SNP genetic risk score, which explained 4.7% of overall IgAN risk, increased sharply with Eastward and Northward distance from Africa (r = 0.30, P = 3×10−128). This model paralleled the known East–West gradient in disease risk. Moreover, the prediction of a South–North axis was confirmed by registry data showing that the prevalence of IgAN–attributable kidney failure is increased in Northern Europe, similar to multiple sclerosis and type I diabetes. Variation at IgAN susceptibility loci correlates with differences in disease prevalence among world populations. These findings inform genetic, biological, and epidemiological investigations of IgAN and permit cross-comparison with other complex traits that share genetic risk loci and geographic patterns with IgAN.


Vyšlo v časopise: Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis. PLoS Genet 8(6): e32767. doi:10.1371/journal.pgen.1002765
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002765

Souhrn

IgA nephropathy (IgAN), major cause of kidney failure worldwide, is common in Asians, moderately prevalent in Europeans, and rare in Africans. It is not known if these differences represent variation in genes, environment, or ascertainment. In a recent GWAS, we localized five IgAN susceptibility loci on Chr.6p21 (HLA-DQB1/DRB1, PSMB9/TAP1, and DPA1/DPB2 loci), Chr.1q32 (CFHR3/R1 locus), and Chr.22q12 (HORMAD2 locus). These IgAN loci are associated with risk of other immune-mediated disorders such as type I diabetes, multiple sclerosis, or inflammatory bowel disease. We tested association of these loci in eight new independent cohorts of Asian, European, and African-American ancestry (N = 4,789), followed by meta-analysis with risk-score modeling in 12 cohorts (N = 10,755) and geospatial analysis in 85 world populations. Four susceptibility loci robustly replicated and all five loci were genome-wide significant in the combined cohort (P = 5×10−32–3×10−10), with heterogeneity detected only at the PSMB9/TAP1 locus (I2 = 0.60). Conditional analyses identified two new independent risk alleles within the HLA-DQB1/DRB1 locus, defining multiple risk and protective haplotypes within this interval. We also detected a significant genetic interaction, whereby the odds ratio for the HORMAD2 protective allele was reversed in homozygotes for a CFHR3/R1 deletion (P = 2.5×10−4). A seven–SNP genetic risk score, which explained 4.7% of overall IgAN risk, increased sharply with Eastward and Northward distance from Africa (r = 0.30, P = 3×10−128). This model paralleled the known East–West gradient in disease risk. Moreover, the prediction of a South–North axis was confirmed by registry data showing that the prevalence of IgAN–attributable kidney failure is increased in Northern Europe, similar to multiple sclerosis and type I diabetes. Variation at IgAN susceptibility loci correlates with differences in disease prevalence among world populations. These findings inform genetic, biological, and epidemiological investigations of IgAN and permit cross-comparison with other complex traits that share genetic risk loci and geographic patterns with IgAN.


Zdroje

1. SchenaFP 1990 A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89 209 215

2. VarisJRantalaIPasternackAOksaHJanttiM 1993 Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol 46 607 610

3. SuzukiKHondaKTanabeKTomaHNiheiH 2003 Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63 2286 2294

4. JulianBAQuigginsPAThompsonJSWoodfordSYGleasonK 1985 Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N Engl J Med 312 202 208

5. O'ConnellPJIbelsLSThomasMAHarrisMEcksteinRP 1987 Familial IgA nephropathy: a study of renal disease in an Australian aboriginal family. Aust N Z J Med 17 27 33

6. LevyM 1989 Familial cases of Berger's disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 87 246 248

7. LiPKBurnsAPSoAKLaiKNReesAJ 1992 Familial IgA nephropathy: a study of HLA class II allogenotypes in a Chinese kindred. Am J Kidney Dis 20 458 462

8. ScolariFAmorosoASavoldiSMazzolaGPratiE 1999 Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis 33 857 865

9. GharaviAGYanYScolariFSchenaFPFrascaGM 2000 IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26 354 357

10. BiscegliaLCerulloGForaboscoPTorresDDScolariF 2006 Genetic Heterogeneity in Italian Families with IgA Nephropathy: Suggestive Linkage for Two Novel IgA Nephropathy Loci. Am J Hum Genet 79 1130 1134

11. PatersonADLiuXQWangKMagistroniRSongX 2007 Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol 18 2408 2415

12. KirylukKMoldoveanuZSandersJTEisonTMSuzukiH 2011 Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis. Kidney Int 80 79 87

13. GharaviAGMoldoveanuZWyattRJBarkerCVWoodfordSY 2008 Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19 1008 1014

14. GharaviAGKirylukKChoiMLiYHouP 2011 Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43 321 7

15. FeehallyJFarrallMBolandAGaleDPGutI 2010 HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 21 1791 1797

16. IzziCSanna-CherchiSPratiEBelleriRRemedioA 2006 Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 69 1033 1040

17. CullenMErlichHKlitzWCarringtonM 1995 Molecular mapping of a recombination hotspot located in the second intron of the human TAP2 locus. Am J Hum Genet 56 1350 1358

18. CullenMNobleJErlichHThorpeKBeckS 1997 Characterization of recombination in the HLA class II region. Am J Hum Genet 60 397 407

19. JeffreysAJRitchieANeumannR 2000 High resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot. Hum Mol Genet 9 725 733

20. LinPIVanceJMPericak-VanceMAMartinER 2007 No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80 531 538

21. BerthouxFCGagneASabatierJCDucretFLe PetitJC 1978 HLA-Bw35 and mesangial IgA glomerulonephritis. N Engl J Med 298 1034 1035

22. BarcellosLFMaySLRamsayPPQuachHLLaneJA 2009 High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 5 doi:10.1371/journal.pgen.1000696Z e1000696

23. NejentsevSHowsonJMWalkerNMSzeszkoJFieldSF 2007 Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 887 892

24. ErlichHValdesAMNobleJCarlsonJAVarneyM 2008 HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57 1084 1092

25. SawcerSHellenthalGPirinenMSpencerCCPatsopoulosNA 2011 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476 214 219

26. EvansDMSpencerCCPointonJJSuZHarveyD 2011 Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43 761 767

27. KastlSPSpeidlWSKaunCKatsarosKMRegaG 2008 In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation. Arterioscler Thromb Vasc Biol 28 498 503

28. WaldherrRRambausekMDunckerWDRitzE 1989 Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4 943 946

29. LiL 1996 End-stage renal disease in China. Kidney Int 49 287 301

30. KoyamaAIgarashiMKobayashiM 1997 Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29 526 532

31. NairRWalkerPD 2006 Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 69 1455 1458

32. OkpechiISwanepoelCDuffieldMMahalaBWearneN 2011 Patterns of renal disease in Cape Town South Africa: a 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant 26 1853 1861

33. HughsonMDMegillDMSmithSMTungKSMillerG 1989 Mesangiopathic glomerulonephritis in Zuni (New Mexico) Indians. Arch Pathol Lab Med 113 148 157

34. FischerEGHarrisAACarmichaelBLathropSLCerilliLA 2009 IgA nephropathy in the triethnic population of New Mexico. Clin Nephrol 72 163 169

35. SmithSMTungKS 1985 Incidence of IgA-related nephritides in American Indians in New Mexico. Hum Pathol 16 181 184

36. SmithSMHarfordAM 1995 IgA nephropathy in renal allografts: increased frequency in Native American patients. Ren Fail 17 449 456

37. CasiroOGStanwickRSWalkerRD 1988 The prevalence of IgA nephropathy in Manitoba Native Indian children. Can J Public Health 79 308 310

38. O'RourkeDHRaffJA 2010 The human genetic history of the Americas: the final frontier. Curr Biol 20 R202 207

39. BorchersATUiboRGershwinME 2010 The geoepidemiology of type 1 diabetes. Autoimmun Rev 9 A355 365

40. GreenAGaleEAPattersonCC 1992 Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet 339 905 909

41. MiloRKahanaE 2010 Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 9 A387 394

42. HandelAEHandunnetthiLGiovannoniGEbersGCRamagopalanSV 2010 Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol 17 1210 1214

43. ShapiraYAgmon-LevinNShoenfeldY 2010 Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34 J168 177

44. BergerJHinglaisN 1968 Les dépôts intercapillaires d'IgA-IgG. J Urol Nephrol (Paris) 74 694 695

45. SuzukiHKirylukKNovakJMoldoveanuZHerrAB 2011 The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22 1795 1803

46. KottgenAPattaroCBogerCAFuchsbergerCOldenM 2010 New loci associated with kidney function and chronic kidney disease. Nat Genet 42 376 384

47. ParkJHWacholderSGailMHPetersUJacobsKB 2010 Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 42 570 575

48. GaudermanWJ 2002 Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155 478 484

49. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575

50. HanBEskinE 2011 Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Genet 88 586 598

51. Huedo-MedinaTBSanchez-MecaJMarin-MartinezFBotellaJ 2006 Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11 193 206

52. CordellHJClaytonDG 2002 A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70 124 141

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#